RE:FDA/NCE/ September S1, always going to be haters.
Made the huge mistake of giving in to their constant negative rhetoric with Canopy Growth in its early days. Lost a potential fortune listening to those jackazzes.
Wont make that mistake again! Labs vision in the pharma space is still early stages so expect some bumps in the road, but a moon shot is just as likely if everything comes together as planned
There is no way this should be trading at 8 pennies, when compared to other debt ridden comparables in the industry.
Reevaluations of company shareprices are coming and long overdue!